NFKB1 and glioblastoma: Our results showed that the pharmacologic inhibition of NF-κB by DHMEQ in GBM cells significantly reduced cell growth (all cell lines were equally sensitive after 72 h) and prompted G2/M arrest in dose- and time-dependent manners while inducing apoptosis through caspase-dependent pathways.